Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

An FDA advisory committee may have ruled in elamipretide’s favor back in October, but it looks like Stealth BioTherapeutics ...

Disc Medicine finalised the pivotal Phase III trial design of bitopertin in erythropoietic protoporphyria (EPP) with the FDA ...

The US Food and Drug Administration (FDA) has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs ...

A New York aesthetician was arrested on Wednesday for allegedly buying counterfeit Botox from China and injecting it into ...

Canada lags behind other developed countries when it comes to the length of time it takes to approve desperately needed ...

A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods gained and the significance of the new drugs and biologics that these ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...